scholarly journals Onset of vitiligo in a psoriasis patient on ixekizumab

2021 ◽  
Author(s):  
Claudio Marasca ◽  
Luigi Fornaro ◽  
Fabrizio Martora ◽  
Vincenzo Picone ◽  
Gabriella Fabbrocini ◽  
...  
Keyword(s):  
Psoriasis Patient

Neutrophil Myeloperoxidase Destruction by Ultraviolet Irradiation

1988 ◽  
Vol 46 ◽  
pp. 138-139
Author(s):  
J. Hanker ◽  
B. Giammara ◽  
G. Strauss
Keyword(s):  
Uv Radiation ◽  
Myeloid Leukemia ◽  
Stratospheric Ozone ◽  
Psoriasis Patient ◽  
Whole Body ◽  
Human Neutrophils ◽  
Cupric Nitrate ◽  
The Earth ◽  
Routine Handling ◽  
Uvb Phototherapy

Only a fraction of the UV radiation emitted by the sun reaches the earth; most of the UVB (290-320nm) is eliminated by stratospheric ozone. There is increasing concern, however, that man-made chemicals are damaging this ozone layer. Although the effects of UV on DNA or as a carcinogen are widely known, preleukemia and acute myeloid leukemia (AML) have only rarely been reported in psoriasis patients treated with 8-methoxypsoralen and UV (PUVA). It was therefore of interest to study the effects of UV on the myeloperoxidase (MP) activity of human neutrophils. The peroxidase activity of enriched leukocyte preparations on coverslips was shown cytochemically with a diaminobenzidine medium and cupric nitrate intensification.Control samples (Figs. 1,4,5) of human bloods that were not specifically exposed to UV radiation or light except during routine handling were compared with samples which had been exposed in one of several different ways. One preparation (Fig. 2) was from a psoriasis patient who had received whole-body UVB phototherapy repeatedly.

Etanercept Tied to Hypoglycemia in Diabetic Psoriasis Patient

2009 ◽  
Vol 40 (5) ◽  
pp. 38
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  
Psoriasis Patient

The Psoriasis Patient Journey: Progression from Topical to Biologic Treatment for Psoriasis Patients in the United States

2018 ◽  
Vol 2 ◽  
pp. S13
Author(s):  
Jashin J Wu ◽  
Minyi Lu ◽  
Karen A Veverka ◽  
Maartje Smulders ◽  
Eros Papademetriou ◽  
...  
Keyword(s):  
United States ◽  
Psoriasis Patient ◽  
The United States ◽  
Biologic Treatment ◽  
Patient Journey

Abstract not available. Disclosures: Study sponssored by LEO Pharma. Copyright 2018 SKIN

NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab

2021 ◽  
Author(s):  
Talora Martin ◽  
Sean Duke ◽  
Veena Kumar ◽  
Ali Fadhil ◽  
Rami Ibrahim ◽  
...  
Keyword(s):  
Psoriasis Patient

scholarly journals Molecular Mechanisms of ZC3H12C/Reg-3 Biological Activity and Its Involvement in Psoriasis Pathology

2021 ◽  
Vol 22 (14) ◽  
pp. 7311
Author(s):  
Mateusz Wawro ◽  
Jakub Kochan ◽  
Weronika Sowinska ◽  
Aleksandra Solecka ◽  
Karolina Wawro ◽  
...  
Keyword(s):  
Family Member ◽  
Cellular Localization ◽  
Molecular Mechanisms ◽  
Inflammatory Diseases ◽  
Association Studies ◽  
Psoriasis Patient ◽  
Genome Wide Association Studies ◽  
Mrna Levels ◽  
Transcript Levels

The members of the ZC3H12/MCPIP/Regnase family of RNases have emerged as important regulators of inflammation. In contrast to Regnase-1, -2 and -4, a thorough characterization of Regnase-3 (Reg-3) has not yet been explored. Here we demonstrate that Reg-3 differs from other family members in terms of NYN/PIN domain features, cellular localization pattern and substrate specificity. Together with Reg-1, the most comprehensively characterized family member, Reg-3 shared IL-6, IER-3 and Reg-1 mRNAs, but not IL-1β mRNA, as substrates. In addition, Reg-3 was found to be the only family member which regulates transcript levels of TNF, a cytokine implicated in chronic inflammatory diseases including psoriasis. Previous meta-analysis of genome-wide association studies revealed Reg-3 to be among new psoriasis susceptibility loci. Here we demonstrate that Reg-3 transcript levels are increased in psoriasis patient skin tissue and in an experimental model of psoriasis, supporting the immunomodulatory role of Reg-3 in psoriasis, possibly through degradation of mRNA for TNF and other factors such as Reg-1. On the other hand, Reg-1 was found to destabilize Reg-3 transcripts, suggesting reciprocal regulation between Reg-3 and Reg-1 in the skin. We found that either Reg-1 or Reg-3 were expressed in human keratinocytes in vitro. However, in contrast to robustly upregulated Reg-1 mRNA levels, Reg-3 expression was not affected in the epidermis of psoriasis patients. Taken together, these data suggest that epidermal levels of Reg-3 are negatively regulated by Reg-1 in psoriasis, and that Reg-1 and Reg-3 are both involved in psoriasis pathophysiology through controlling, at least in part different transcripts.

scholarly journals Plantar pustules in a psoriasis patient during the guselkumab therapy

2021 ◽  
Author(s):  
Shinsuke Nakazawa ◽  
Tetsuya Honda
Keyword(s):  
Psoriasis Patient

The Effect of Practolol, In Vitro Generated Metabolites of Practolol and Chemical Analogues on the Rate of Growth of Human Skin Fibroblasts

1984 ◽  
Vol 12 (2) ◽  
pp. 89-97
Author(s):  
Graham R. Elliott ◽  
H.E. Amos ◽  
James W. Bridges
Keyword(s):  
Human Skin ◽  
Psoriasis Patient ◽  
Skin Fibroblasts ◽  
Human Skin Fibroblasts ◽  
Cell Type ◽  
Normal Human Skin ◽  
Rate Of Growth ◽  
Structural Analogues ◽  
Normal Human

The rate of growth of normal human skin fibroblasts was inhibited in a dose related, reversible, fashion by practolol (N-4-(2-hydroxy)-3 (1-methyl)-aminopropoxyphenylacetamine) (ID50 1.35 ± 0.14 x 10-3M), propranolol (1-(isopropylamino)-3(1-naphthyl-oxy)-2-propranolol) (ID50 0.145 ± 0.02 x 10-3M) and paracetamol (N-(4-hydroxyphenyl) acetamide) (ID50 0.85 ± 0.2 x 10-3M). Skin fibroblasts isolated from a psoriasis patient were more sensitive towards practolol (ID50 0.48 ± 0.14 x 10-3M) and propranolol (ID50 0.032 ± 0.002 x 10-3M), but less sensitive towards paracetamol (ID50 1.3 ± 0.07 x 10-3M). In vitro generated metabolites of practolol, using normal or Arochlor 1254-pretreated hamster liver preparations, and structural analogues of practolol had no effect upon the growth of either cell type.

scholarly journals Fatal Thrombotic Thrombocytopenic Purpura in a Psoriasis Patient Treated with Ustekinumab and Methotrexate

2015 ◽  
Vol 95 (4) ◽  
pp. 495-496 ◽  
Author(s):  
L Philippe ◽  
J Badie ◽  
J Faller ◽  
É Krattinger ◽  
E Deconinck ◽  
...  
Keyword(s):  
Thrombotic Thrombocytopenic Purpura ◽  
Psoriasis Patient ◽  
Thrombocytopenic Purpura

A 60 degree celcius of Gasserian ganglion ablation with improvement on psoriasis patient with trigeminal neuralgia: A case report

2021 ◽  
Vol 429 ◽  
pp. 118617
Author(s):  
Rina Astuti ◽  
Yani Arlina ◽  
Savitri Shitarukmi
Keyword(s):  
Case Report ◽  
Trigeminal Neuralgia ◽  
Psoriasis Patient ◽  
Gasserian Ganglion
Sign in / Sign up

Export Citation Format

Share Document